Dr. Obedin-Maliver is a board-certified obstetrician/gynecologist who is both clinically and academically active. Dr. Obedin-Maliver is an Assistant Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at The University of California, San Francisco and The Chief of Gynecology at The San Francisco Veterans Affairs Medical Center (SFVAMC) where she provides full-spectrum gynecology care.
Her academic focus is on promoting the health of and well-being sexual and gender minorities (SGM) which include but are not limited to lesbian, gay, bisexual, and transgender, and queer (LGBTQ) people. A special emphasis that combined her clinical and academic interests is the focus on the reproductive health of transgender and gender expansive individuals.
Dr. Obedin-Maliver, is a co-founder and current investigator of The Stanford Lesbian, Gay, Bisexual and Transgender Medical Education Research Group (LGBT MERG) and a Co-Director of The PRIDE Study (pridestudy.org), an online prospective longitudinal cohort of sexual and gender minority individuals based at University of California, San Francisco. She is Co-Investigator of PRIDEnet, a participant powered research network of sexual and gender minority people (pridestudy.org/pridenet) whose mission is to help catalyze LGBTQ Health Research. She also serves on the medical advisory board of the UCSF Center of Excellence for Transgender Health and is the Gynecology Lead on the Transgender Quality Improvement project at SFVAMC and is involved in many other national and international research projects that promote health equity for LGBTQ and SGM people.
Dr. Obedin-Maliver has also been active in health policy through helping to legally redefine consideration of sexually intimate partner status and remove the Medicare Non-Coverage Determination ruling on “transsexual surgery.” Other areas of active clinical, research, and advocacy activities include the genitourinary, gynecological, and obstetrical health of transgender people and women and the health of veterans.